Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Romark Laboratories, L.C.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness

Phase 3

Not yet recruiting

Conditions: COVID-19

Interventions: Drug: Nitazoxanide
Dietary Supplement: Vitamin Super-B Complex
Drug: Placebo
Other: Standard of Care

First Posted Date: 2021-12-14

Last Posted Date: 2023-09-29

Lead Sponsor: Romark Laboratories L.C.

Target Recruit Count: 2000

Registration Number: NCT05157243

Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe Illness

Phase 3

Not yet recruiting

Conditions: COVID-19

Interventions: Drug: Placebo
Drug: Nitazoxanide
Dietary Supplement: Vitamin Super-B Complex

First Posted Date: 2021-12-14

Last Posted Date: 2023-09-29

Lead Sponsor: Romark Laboratories L.C.

Target Recruit Count: 600

Registration Number: NCT05157269

Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection

Phase 3

Terminated

Conditions: Enterovirus
Rhinovirus

Interventions: Drug: Nitazoxanide
Drug: Placebo
Dietary Supplement: Vitamin Super B-Complex

First Posted Date: 2020-07-28

Last Posted Date: 2024-10-17

Lead Sponsor: Romark Laboratories L.C.

Target Recruit Count: 214

Registration Number: NCT04489381

Locations: 🇺🇸
HealthStar Research LLC, Hot Springs, Arkansas, United States
🇺🇸
Invesclinic US LLC, Fort Lauderdale, Florida, United States
🇺🇸
RH Medical Urgent Care, Bronx, New York, United States

Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19

Phase 3

Completed

Conditions: COVID-19

Interventions: Drug: Nitazoxanide
Drug: Placebo
Dietary Supplement: Vitamin Super B-Complex

First Posted Date: 2020-07-24

Last Posted Date: 2024-03-29

Lead Sponsor: Romark Laboratories L.C.

Target Recruit Count: 935

Registration Number: NCT04486313

Locations: 🇺🇸
Invesclinic US LLC, Fort Lauderdale, Florida, United States
🇺🇸
RH Medical Urgent Care, Bronx, New York, United States

Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection

Phase 3

Completed

Conditions: COVID-19
Viral Respiratory Illnesses

Interventions: Drug: Placebo
Drug: Nitazoxanide
Dietary Supplement: Vitamin Super B-Complex

First Posted Date: 2020-04-24

Last Posted Date: 2024-06-26

Lead Sponsor: Romark Laboratories L.C.

Target Recruit Count: 1407

Registration Number: NCT04359680

Locations: 🇺🇸
The Chappel Group Research, Kissimmee, Florida, United States
🇺🇸
Chicago Medical Research Institute, Inc., Chicago, Illinois, United States
🇺🇸
Chicago Clinical Research Institute, Inc., Chicago, Illinois, United States

and more 22 locations

Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF)

Phase 3

Terminated

Conditions: COVID-19
Viral Respiratory Illnesses

Interventions: Drug: Placebo
Drug: Nitazoxanide
Dietary Supplement: Vitamin Super B-Complex

First Posted Date: 2020-04-13

Last Posted Date: 2024-07-08

Lead Sponsor: Romark Laboratories L.C.

Target Recruit Count: 190

Registration Number: NCT04343248

Locations: 🇺🇸
The Chappel Group Research, Kissimmee, Florida, United States
🇺🇸
Clinical Trial Specialists, Inc., Acworth, Georgia, United States
🇺🇸
Centex Studies, Inc., Houston, Texas, United States

Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis B

Phase 2

Completed

Conditions: Chronic Hepatitis B

Interventions: Drug: Placebo Oral Tablet
Drug: Nitazoxanide

First Posted Date: 2019-04-05

Last Posted Date: 2023-11-07

Lead Sponsor: Romark Laboratories L.C.

Target Recruit Count: 51

Registration Number: NCT03905655

Locations: 🇸🇬
National University Hospital, Singapore, Singapore

Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection

Phase 3

Completed

Conditions: Rhinovirus
Enterovirus

Interventions: Drug: Nitazoxanide
Drug: Placebo

First Posted Date: 2018-07-30

Last Posted Date: 2022-04-14

Lead Sponsor: Romark Laboratories L.C.

Target Recruit Count: 1756

Registration Number: NCT03605862

Locations: 🇵🇷
Vanguard Study Site, San Juan, Puerto Rico

A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza

Phase 3

Completed

Conditions: Influenza

Interventions: Drug: Nitazoxanide
Drug: Placebo

First Posted Date: 2017-11-08

Last Posted Date: 2022-06-28

Lead Sponsor: Romark Laboratories L.C.

Target Recruit Count: 1030

Registration Number: NCT03336619

Locations: 🇵🇷
Vanguard Study Site, Ponce, Puerto Rico

Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza

Phase 3

Completed

Conditions: Influenza

Interventions: Drug: Placebo
Drug: Nitazoxanide

First Posted Date: 2015-11-24

Last Posted Date: 2018-04-04

Lead Sponsor: Romark Laboratories L.C.

Target Recruit Count: 325

Registration Number: NCT02612922

Locations: 🇵🇷
Influence Study Site, San Juan, Puerto Rico

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy